VEGFR2/KDR/Flk-1 Antibody, Novus Biologicals™

VEGFR2/KDR/Flk-1

Western Blot 1:250-1:1000, Flow Cytometry reported in scientific literature (PMID 29873146), Immunohistochemistry reported in scientific literature (PMID 30941660), Immunocytochemistry/Immunofluorescence 1:50 - 1:500

Polyclonal

Rabbit

Angiogenesis, Cancer, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases

Tris-Glycine, 0.15 M NaCl with 0.05% Sodium Azide

3791

A synthetic peptide made to a C-terminal region of the mouse VEGF Receptor 2 protein (between residues 1300-1367). [Swiss-Prot# P35918]

Primary

Store at 4C. Do not freeze.

150 kDa

2.55 mg/mL

Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence

Unconjugated

RUO

Human, Mouse, Rat

CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2

KDR

IgG

Affinity Purified

Human and mouse. Predicted to react with rat based on 100% sequence homology.